Status:
COMPLETED
A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)
Lead Sponsor:
Eisai Co., Ltd.
Conditions:
Refractory Partial Seizures
Eligibility:
All Genders
20-64 years
Phase:
PHASE2
Brief Summary
The purpose of this trial is to investigate the safety and tolerability of perampanel in long- term treatment in the patients with refractory partial epilepsy (uncontrolled with other anti-epileptic d...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients who consent to the study entry on their free will before starting any trial-related activities.
- Patients who participated in Study 231 and completed the required evaluation period (10 weeks).
- Patients who are certainly and voluntarily able to participate in this study and record their seizures by themselves or have family members or caregivers (or nurses, if hospitalized) record the seizures. Patients who wish to continue perampanel treatment and necessitate receiving the long- term administration judged by the investigator or sub-investigator.
- Exclusion criteria:
- Pregnant or lactating women, women of child-bearing potential, women willing to become pregnant.
- Patients who are ineligible judged by the investigator or sub investigator in light of medical history or complication at enrollment in treatment period.
- Patients who operate heavy equipment or drive should not be recruited into the study.
- Patients who are ineligible for study entry judged by the investigator or sub-investigator.
Exclusion
Key Trial Info
Start Date :
June 17 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2016
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT00903786
Start Date
June 17 2009
End Date
October 31 2016
Last Update
August 29 2018
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Kitakyushu, Fukuoka, Japan
2
Kobe, Hyōgo, Japan
3
Sendai, Miyagi, Japan
4
Komatsushimachō, Tokushima, Japan